Estados Unidos - inglés - NLM (National Library of Medicine)

ax pharmaceutical corp - albendazole (unii: f4216019ln) (albendazole - unii:f4216019ln) - albendazole 247.5 g in 250 g

Estados Unidos - inglés - NLM (National Library of Medicine)

pharma packaging solutions, llc dba tjoapack llc - albendazole (unii: f4216019ln) (albendazole - unii:f4216019ln) - albendazole tablets are indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, taenia solium. albendazole tablets are indicated for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, echinococcus granulosus. albendazole tablets are contraindicated in patients with known hypersensitivity to the benzimidazole class of compounds or any components of albendazole tablets. risk summary based on findings from animal reproduction studies, albendazole tablets may cause fetal harm when administered to a pregnant woman. however, available human data from a small number of published case series and reports on the use of multiple-dose albendazole in the 1 st trimester of pregnancy, and several published studies on single-dose albendazole use later in pregnancy, have not identified any drug-associated risks for major birth defects, miscarriage, or adverse mater

Estados Unidos - inglés - NLM (National Library of Medicine)

zoetis inc. - albendazole (unii: f4216019ln) (albendazole - unii:f4216019ln) - albendazole 113.6 mg in 1 ml - cattle and sheep: valbazen is a broad-spectrum anthelmintic effective in the removal and control of liver flukes, tapeworms, stomach worms (including 4th stage inhibited larvae of ostertagia ostertagi ), intestinal worms, and lungworms as indicated below. goats: for the treatment of adult liver flukes in nonlactating goats.

Tanzania - inglés - Tanzania Medicinces & Medical Devices Authority

salama pharmaceuticals limited, tanzania - albendazole - solution, oral - 2.5%

Uganda - inglés - National Drug Authority

hebei kexing pharmaceutical co., ltd. - albendazole - oral liquid ordinary suspensions - 10%w/v

Estados Unidos - inglés - NLM (National Library of Medicine)

mckesson rxpak inc - albendazole (unii: f4216019ln) (albendazole - unii:f4216019ln) - albendazole 200 mg - albenza is indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, taenia solium . albenza is indicated for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, echinococcus granulosus . albenza is contraindicated in patients with known hypersensitivity to the benzimidazole class of compounds or any components of albenza. pregnancy category c. there are no adequate and well-controlled studies of albenza administration in pregnant women. albenza should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. albenza should not be used in pregnant women except in clinical circumstances where no alternative management is appropriate. obtain pregnancy test prior to prescribing albenza to women of reproductive potential. advise women of reproductive potential to use effective birth control for the duration of albenza therapy and for

Estados Unidos - inglés - NLM (National Library of Medicine)

spectrum laboratory products, inc. - albendazole (unii: f4216019ln) (albendazole - unii:f4216019ln) -

Estados Unidos - inglés - NLM (National Library of Medicine)

bluebay shandong co.,ltd - albendazole (unii: f4216019ln) (albendazole - unii:f4216019ln) -

Kenia - inglés - Pharmacy and Poisons Board

vetagro and pulpers company ltd po box 2345-00100 nairobi - albendazole 25mg - oral suspension - albendazole - antinematodal anthelmintic agents:

Kenia - inglés - Pharmacy and Poisons Board

metrovet(k)ltd po box 1601-00100 nairobi - albendazole 2500mg - tablet - albendazole 2500mg - antibacterials for systemic use: tetracyclines